Market Cap: $15.26B
AA
Ascendis Pharma A/S
ASND
NASDAQ (NASDAQ Global Select)USD
Market Cap: $15.26B
Regulatory Success: Yuviwel Approval Marks a Major Milestone for Ascendis Pharma Ascendis Pharma A/S achieves a significant milestone with the recent approval of Yuviwel (navepegritide) by the U.S. Fo…
Ascendis Pharma Secures FDA Approval for Yuviwel, Advancing Pediatric Care for Achondroplasia Ascendis Pharma A/S achieves a significant milestone with the recent U.S. Food and Drug Administration (FD…
Yuviwel’s FDA Approval Marks a Milestone for Ascendis Pharma in Pediatric Treatment Ascendis Pharma A/S achieves a significant breakthrough with the recent approval from the U.S. Food and Drug Adminis…
Ascendis Pharma's Short Interest Surge: Implications for the Biotech Sector Ascendis Pharma A/S, a biotechnology company focused on innovative treatments, faces a significant rise in short interest, w…
Open
$274.56
Prev. Close
$243.45
High
$274.56
Low
$269.605